$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Improvement of skin whitening agents efficiency through encapsulation: Current state of knowledge

International journal of pharmaceutics, v.526 no.1/2, 2017년, pp.50 - 68  

Ephrem, E. ,  Elaissari, H. ,  Greige-Gerges, H.

Abstract AI-Helper 아이콘AI-Helper

Hyperpigmentation is one of the most common skin disorder that affects both men and women of all ethnic groups, caused by several factors, such as UV exposure and skin inflammation. Topical whitening agents were found to be the best and the least aggressive therapy for treating hyperpigmentation com...

주제어

참고문헌 (229)

  1. Int. J. Pharm. Abioye 490 112 2015 10.1016/j.ijpharm.2015.05.030 Ex vivo skin permeation and retention studies on chitosan-ibuprofen-gellan ternary nanogel prepared by in situ ionic gelation technique − A tool for controlled transdermal delivery of ibuprofen 

  2. Biochim. Biophys. Acta Abraham 1021 119 1990 10.1016/0005-2736(90)90023-H Interaction between corneocytes and stratum corneum lipid liposomes in vitro 

  3. Agostini, A., Balzi, S., 2014. Compositions containing resveratrol and essential oil of cloves for the treatment of itching. US patent 20100079835A1. 

  4. Trends Appl. Sci. Res. Ajibola 4 79 2009 10.3923/tasr.2009.79.84 The effect of storage method on the vitamin C content in some tropical fruit juices 

  5. Nanoscale Res. Lett. Akbarzadeh 8 102 2013 10.1186/1556-276X-8-102 

  6. Am. J. Clin. Dermatol. Akhavan 4 473 2003 10.2165/00128071-200304070-00004 Topical acne drugs: review of clinical properties, systemic exposure, and safety 

  7. Bull. Chem. Soc. Ethiopia Akhtar 24 1 2010 10.4314/bcse.v24i1.52955 Formulation and characterization of a multiple emulsion 1% L-ascorbic acid 

  8. Fitoterapia Ali 76 128 2005 10.1016/j.fitote.2004.10.015 Flavonoids from blumea balsamifera 

  9. Food Chem. Alishahi 126 935 2011 10.1016/j.foodchem.2010.11.086 Shelf life and delivery enhancement of vitamin C using chitosan nanoparticles 

  10. Colloids Surf. B Biointerfaces Alomrani 121 74 2014 10.1016/j.colsurfb.2014.05.030 Itraconazole hydroxypropyl-β-cyclodextrin loaded deformable liposomes: in vitro skin penetration studies and antifungal efficacy using Candida albicans as model 

  11. Int. J. Dermatol. Amer 39 299 2000 10.1046/j.1365-4362.2000.00943.x Topical liquiritin improves melasma 

  12. J. Lipid Res. Ando 40 1312 1999 10.1016/S0022-2275(20)33493-3 Possible involvement of proteolytic degradation of tyrosinase in the regulatory effect of fatty acids on melanogenesis 

  13. Biochem. J. Ando 394 43 2006 10.1042/BJ20051419 Intracellular composition of fatty acid affects the processing and function of tyrosinase through the ubiquitinproteasome pathway 

  14. Pharm. Sci. Technol. Ansari 12 279 2011 10.1208/s12249-011-9584-3 Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study 

  15. Nat. Prod. Commun. Ao 5 1907 2010 Factors influencing glabridin stability 

  16. Khartoum Pharm. J. Arbab 13 5 2010 Review on skin whitening agents 

  17. Chem. Pharm. Bull. Arima 44 582 1996 10.1248/cpb.44.582 Possible enhancing mechanism of the cutaneous permeation of 4-biphenylylacetic acid by beta-cyclodextrin derivatives in hydrophilic ointment 

  18. Eur. J. Pharm. Sci. Arima 6 53 1998 10.1016/S0928-0987(97)00068-7 Enhancing effect of hydroxypropyl-β-cyclodextrin on cutaneous penetration and activation of ethyl 4-biphenylyl acetate in hairless mouse skin 

  19. Aust, D.T., Ross, M.A., Wilmott, J.M., Hayward J.A., 2001. Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts. US patent 6183774 B1. 

  20. Avdeef 1997 Seminar on Ionization and Lipophilicity: Log P Values Measured 

  21. Surg. Cosmet. Dermatol. Ayres 7 303 2015 Ex vivo study for evaluating the whitening activity of Pycnogenol® after exposure to ultraviolet and infrared radiations, and visible light 

  22. J. Drugs Dermatol. Badreshia-Bansal 6 32 2007 Insight into skin lightening cosmeceuticals for women of color 

  23. J. Microbiol. Biotechnol. Baek 18 874 2008 Inhibitory effect of dalbergioidin isolated from the trunk of Lespedeza cyrtobotrya on melanin biosynthesis 

  24. PLoS One Bajaj 7 e30899 2012 10.1371/journal.pone.0030899 Zwitterionic chitosan derivative, a new biocompatible pharmaceutical excipient, prevents endotoxin-mediated cytokine release 

  25. J. Sep. Sci. Balaguer 31 229 2008 10.1002/jssc.200700414 Environmentally friendly LC for the simultaneous determination of ascorbic acid and its derivatives in skin-whitening cosmetics 

  26. Drug Dev. Ind. Pharm Beckers 17 1503 1991 10.3109/03639049109026630 Cyclodextrin in the pharmaceutical field 

  27. J. Pharm. Pharmacol. Bentley 49 397 1997 10.1111/j.2042-7158.1997.tb06813.x Characterization of the influence of some cyclodextrins on the stratum corneum from the hairless mouse 

  28. Nat. Prod. Rep. Bentley 23 1046 2006 10.1039/b603758p From miso, saké and shoyu to cosmetics: a century of science for kojic acid 

  29. Int. J. Cosmet. Sci. Bernard 22 219 2000 10.1046/j.1467-2494.2000.00019.x Resveratrol: an original mechanism on tyrosinase inhibition 

  30. J. Inclusion Phenom. Macrocyclic Chem. Bertacche 55 279 2006 10.1007/s10847-006-9047-8 Host-guest interaction study of resveratrol with natural and modified cyclodextrins 

  31. J. Korean Pharm. Sci. Bian 36 299 2006 Deformable liposomes for topical skin delivery of arbutin 

  32. Exp. Dermatol. Boissy 8 601 2005 10.1111/j.0906-6705.2005.00337.x DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency 

  33. Botello, A.F., Viladot Petit, J.L., Delgado Gonzalez, R., 2013. Liposomes for the treatment of textile materials. US patent 20130183358 A1. 

  34. Int. J. Pharm. Bouchemal 280 241 2004 10.1016/j.ijpharm.2004.05.016 Nanoemulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimization 

  35. Leuk. Res. Bourogaa 35 1093 2011 10.1016/j.leukres.2010.12.011 Hammada scoparia flavonoids and rutin kill adherent and chemoresistant leukemic cells 

  36. Med. Hypotheses. Breathnach 52 221 1999 10.1054/mehy.1997.0647 Azelaic acid: potential as a general antitumoural agent 

  37. Pigment Cell Res. Briganti 16 101 2003 10.1034/j.1600-0749.2003.00029.x Chemical and instrumental approaches to treat hyperpigmentation 

  38. Pharm. Acta Helv. Brisaert 70 161 1995 10.1016/0031-6865(95)00016-3 Chemical stability of tretinoin in dermatological preparation 

  39. Int. J. Pharm. Brisaert 197 153 2000 10.1016/S0378-5173(99)00462-7 Investigation of the chemical stability of an erythromycin-tretinoin lotion by the use of an optimization system 

  40. Int. J. Toxicol. Burnett 29 244 2010 10.1177/1091581810385956 Final report of the safety assessment of kojic acid as used in cosmetics 

  41. Int. J. Pharm. Caddeo 363 183 2008 10.1016/j.ijpharm.2008.07.024 Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells 

  42. Carson 2001 Cosmetic Compositions Containing Resveratrol. UD6270780 B1 

  43. Cattaneo, M., 2004. Chitosan microparticles for the topical delivery of water insoluble active agents. US patent 20040247632A1. 

  44. Biomed. Microdevices Celia 14 119 2012 10.1007/s10544-011-9590-y Ethosomes® and transferosomes® containing linoleic acid: physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders 

  45. J. Cont. Release Cevc 45 211 1997 10.1016/S0168-3659(96)01566-0 Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo 

  46. Adv. Drug Deliv. Rev. Cevc 56 675 2004 10.1016/j.addr.2003.10.028 Lipid vesicles and other colloids as drug carriers on the skin 

  47. PLoS One Chai 10 e0145483 2015 10.1371/journal.pone.0145483 Proanthocyanidins extracted from Rhododendron pulchrum leaves as source of tyrosinase inhibitors: sructure, activity, and mechanism 

  48. AAPS Pharm. Sci. Technol. Challa 6 329 2005 10.1208/pt060243 Cyclodextrins in drug delivery: an updated review 

  49. J. Agric. Food Chem. Chang 55 2010 2007 10.1021/jf063095i Two potent suicide substrates of mushroom tyrosinase: 7, 8, 4'-trihydroxyisoflavone and 5, 7, 8,4'-tetrahydroxyisoflavone 

  50. Exp. Dermatol. Chao 22 131 2013 10.1111/exd.12089 Arthrophytum scoparium inhibits melanogenesis through the down-regulation of tyrosinase and melanogenic gene expressions in B16 melanoma cells 

  51. Int. J. Pharm.Technol. Chaudhari 3 774 2011 Cosmeceuticals −a review 

  52. Chen, M., Sun, P., Date, A., Yuyama, E., Bissett, D., 2006. Skin care composition. US patent 20060018861A1. 

  53. Int. J. Dermatol. Choi 49 218 2010 10.1111/j.1365-4632.2009.04336.x Effects of vitamin C vs. multivitamin on melanogenesis: comparative study in vitro and in vivo 

  54. Int. J. Pharm. Coderch 139 197 1996 10.1016/0378-5173(96)04620-0 Percutaneous penetration of liposomes using the tape stripping technique 

  55. Phamt. Ind. Coiffard 61 574 1999 Degradation kinetics of arbutin in Solution 

  56. J. Med. Food Costa 17 1103 2014 10.1089/jmf.2013.0116 Flavonoid detection in hydroethanolic extract of Pouteria torta (Sapotaceae) leaves by HPLC-DAD and the determination of its mutagenic activity 

  57. Fitoterapia D’Andrea 81 724 2010 10.1016/j.fitote.2010.06.011 Pycnogenol: a blend of procyanidins with multifaceted therapeutic applications? 

  58. Biotechnol. J. Das 1 420 2006 10.1002/biot.200600012 Essential fatty acids: biochemistry, physiology and pathology 

  59. Sci De Vringer 4 466 1995 Preparation and structure of a water-in-oil creamcontaining lipid nanoparticles. J of Pharm 

  60. Doumeix Tome 1 2001 Opérations unitaires en génie biologique 

  61. Dermatol. Ther. Draelos 20 308 2007 10.1111/j.1529-8019.2007.00144.x Skin lightening preparations and the hydroquinone controversy 

  62. Int. J. Pharm. Stud. Res. Dua 3 14 2012 Liposome: methods of preparation and applications 

  63. J. Sci. ind. Res. Dutta 63 20 2004 Chitin and chitosan: chemistry, properties and applications 

  64. European medicines agency (EMA) 2014 Background Review for Cyclodextrins Used as Excipients 

  65. Ehrenberg, J., Najdek, L., Ciriello, E., 1999. Stabilized whitening compositions and method of preparing same. WO patent 1999036053A1. 

  66. Sci. Rev. Chem. Commun. Ekambaram 2 80 2012 Solid lipid nanoparticles: a review 

  67. J. Parm. Pharmacol. El Maghraby 58 415 2006 10.1211/jpp.58.4.0001 Can drug-bearing liposomes penetrate intact skin? 

  68. Arch. Dermatol. Elewski 139 1444 2003 10.1001/archderm.139.11.1444 A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of Papulopustular Rosacea 

  69. J. Cosmet. Sci. Esposito 55 253 2004 Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study 

  70. Förster 395 1998 Modern Aspects of Emulsion Science Applications of emulsions 

  71. FDA, 2013. Personal Care Products Council. 10-30-2013. Concentration of Use by FDA Product Category: Tocopherol and Related Ingredients. Unpublished data submitted by Personal Care Products Council. 

  72. Int. J. Pharm. Fang 219 61 2001 10.1016/S0378-5173(01)00627-5 Effect of liposomes and niosomes on skin permeation of enoxacin 

  73. Chem. Eng. News Fox 59 18 1981 10.1021/cen-v059n043.p018 Fatty acids' spontaneous oxidation clarified 

  74. Fitoterapia Fukai 74 624 2003 10.1016/S0367-326X(03)00164-3 Preliminary evaluation of antinephritis and radical scavenging activities of glabridin from glycyrrhiza glabra 

  75. Biosci. Biotechnol. Biochem. Funayama 59 143 1995 10.1271/bbb.59.143 Effects of alpha- and beta-arbutin on activity of tyrosinases from mushroom and mouse melanoma 

  76. Int. J. Pharm. Gallarate 188 233 1999 10.1016/S0378-5173(99)00228-8 On the stability of ascorbic acid in emulsified systems for topical and cosmetic use 

  77. J. Cosmet. Sci. Gallarate 55 139 2004 Photostability of naturally occurring whitening agents in cosmetic microemulsions 

  78. Int. Curr. Pharm. J. Garud 1 384 2012 10.3329/icpj.v1i11.12065 Solid lipid nanoparticles (SLN): method, characterization and applications 

  79. Int. J. Nanomed. Gokce 7 1841 2012 10.2147/IJN.S29710 Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications 

  80. Dermatology Gollnick 206 29 2003 10.1159/000067820 Topical treatment in acne: current status and future aspects 

  81. Gupta, S., 2005. Liposomal delivery system for topical pharmaceutical, cosmeceutical, and cosmetic ingredients. US patent 20050079210 A1. 

  82. Food Chem. Hadaruga 99 500 2006 10.1016/j.foodchem.2005.08.012 Thermal stability of the linoleic acid/ß- and ß-cyclodextrin complexes 

  83. Int. J. Dermatol. Handog 48 896 2009 10.1111/j.1365-4632.2009.04130.x A randomized, double-blind, placebo-controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women 

  84. Hansch 1995 Exploring QSAR-hydrophobic, Electronic, and Steric Constants 

  85. Hatae, S., Nakashima, K., 1989. Whitening cosmetic. US patent 4847074A. 

  86. Hatae, S., 1992. Use of kojic acid or its beta-cyclodextrin inclusion complex for the prevention of elastosis. EP 0207499 B1. 

  87. Eur. J. Pharm. Biopharm. Herbig 85 158 2013 10.1016/j.ejpb.2013.06.022 Correlation of hydrotropic solubilization by urea with logD of drug molecules and utilization of this effect for topical formulations 

  88. J. Pharm. Pharmacol. Hibatallah 51 1435 1999 10.1211/0022357991777083 In-vivo and in-vitro assessment of the free-radical-scavenger activity of Ginkgo flavone glycosides at high concentration 

  89. Phytother. Res. Hori 18 475 2004 10.1002/ptr.1456 Structural criteria for depigmenting mechanism of arbutin 

  90. J. Oleo. Sci. Hsieh 61 483 2012 10.5650/jos.61.483 Preparing glabridin-in-water nanoemulsion by high pressure homogenization with response surface methodology 

  91. Biopolym. Renew. Resour. (Springer-Verlag, New York) Hudson 96 1998 10.1007/978-3-662-03680-8_4 Polysaccharide: chitin and chitosan: chemistry and technology of their use as structural materials 

  92. Int. J. Pharm. Iervolino 198 229 2000 10.1016/S0378-5173(00)00346-X Membrane penetration enhancement of ibuprofen using supersaturation 

  93. Int. J. Pharm. Iqbal 496 173 2015 10.1016/j.ijpharm.2015.10.057 Double emulsion solvent evaporation techniques used for drug encapsulation 

  94. Skin Pharmacol. Physiol. Izquierdo 20 263 2007 10.1159/000106076 A study on the influence of emulsion droplet size on the skin penetration of tetracaine 

  95. Cesk. Farm. Jahodar 34 174 1985 Antimicrobial action of arbutin and the extracts from leaves of Arctostaphylos uva-ursi in vitro 

  96. Science Jang 275 218 1997 10.1126/science.275.5297.218 Cancer chemopreventive activity of resveratrol, a natural product derived from grapes 

  97. Eur. J. Pharm. Biopharm. Jensen 79 68 2011 10.1016/j.ejpb.2011.05.012 In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin 

  98. Int. J. Cosmet. Sci. Jeon 37 567 2015 10.1111/ics.12228 Simultaneous determination of arbutin and its decomposed product hydroquinone in whitening creams using high-performance liquid chromatography with photodiode array detection: effect of temperature and pH on decomposition 

  99. Exp. Mol. Med. Jung 33 131 2001 10.1038/emm.2001.23 Stimulation of melanogenesis by glycyrrhizin in B16 melanoma cells 

  100. Eur. J. Pharm. Biopharm. Jurkovic 56 59 2003 10.1016/S0939-6411(03)00062-6 Skin protection against ultraviolet induced free radicals with ascorbyl palmitate in microemulsions 

  101. J. Am. Acad. Dermatol. Kameyama 34 29 1996 10.1016/S0190-9622(96)90830-0 Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo 

  102. Kang, H.S., Kang, S.H., Kim, J.H., NA, Y.J., Cho, J.C., Chae, B.G., 2015. Cosmetic composition for skin whitening. US patent 9079047 B2. 

  103. J. Microencapsul. Kas 14 689 1997 10.3109/02652049709006820 Chitosan: properties, preparations and application to microparticulate systems 

  104. J. Invest. Dermatol. Kim 128 1227 2008 10.1038/sj.jid.5701177 Downregulation of melanin synthesis by haginin A and its application to in vivo lightening model 

  105. Biol. Pharm. Bull. Kim 32 264 2009 10.1248/bpb.32.264 Inhibitory effects of calycosin isolated from the root of Astragalus membranaceus on melanin biosynthesis 

  106. Ann. Dermatol. Kim 24 1 2012 10.5021/ad.2012.24.1.1 Topical hypopigmenting agents for pigmentary disorders and their mechanisms of action 

  107. J. Agric. Food Chem. Kim 62 725 2014 10.1021/jf404220n Preparation of a capsaicin-loaded nanoemulsion for improving skin penetration 

  108. Biochim. Biophys. Acta Kirjavainen 1304 179 1996 10.1016/S0005-2760(96)00126-9 Interaction of liposomes with human skin in vitro-the influence of lipid composition and structure 

  109. Biochim. Biophys. Acta Kirjavainen 1304 179 1996 10.1016/S0005-2760(96)00126-9 Interaction of liposomes with human skin in vitro-the influence of lipid composition and structure 

  110. Inorg. Chem. Acta Kontoghiorghes 151 101 1988 10.1016/S0020-1693(00)91889-9 Structure/red blood cell permeability: activity of iron(III) chelator complexes 

  111. Dermatol. Surg. Kopera 21 994 1995 10.1111/j.1524-4725.1995.tb00545.x Ruby laser treatment of melasma and ostinflammatory hyperpigmentation 

  112. Adv. Drug Deliv. Rev. Kreilgaard 54 77 2002 10.1016/S0169-409X(02)00116-3 Influence of microemulsions on cutaneous drug delivery 

  113. Eur. J. Pharm. Sci. Kristl 19 181 2003 10.1016/S0928-0987(03)00104-0 Effect of colloidal carriers on ascorbyl palmitate stability 

  114. J. Agric. Food Chem. Kubo 47 4121 1999 10.1021/jf990201q Flavonols from saffron flower: tyrosinase inhibitory activity and inhibition mechanism 

  115. Bioorg. Med. Chem. Kubo 8 1749 2000 10.1016/S0968-0896(00)00102-4 Flavonols from Heterotheca inuloides: tyrosinase inhibitory activity and structural criteria 

  116. J. Cosmet. Dermatol. Sci. Appl. López-García 5 62 2015 Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): occlusive effect and penetration enhancement ability 

  117. J. Biomed. Biotechnol. Lajis 2012 1 2012 10.1155/2012/952452 Depigmenting effect of kojic acid esters in hyperpigmented B16F1 melanoma cells 

  118. J. Miner. Metall. Mater. Leelapornpisid 20 101 2010 Application of chitosan for preparation of arbutin nanoparticles as skin whitening 

  119. Eur. J Pharm. Sci. Legendre 3 311 1995 10.1016/0928-0987(95)00020-0 Effects of b-cyclodextrins on skin: implications for the transdermal delivery of piribedil and a novel cognition enhancing-drug, S-9977 

  120. Anal. Biochem. Lei 305 260 2002 10.1006/abio.2002.5665 A melanocyte keratinocyte coculture model to assess regulators of pigmentation in vitro 

  121. Exp. Dermatol. Lemic-Stoicevic 4 79 1995 10.1111/j.1600-0625.1995.tb00226.x Effect of azelaic acid on melanoma cell in culture 

  122. Asian J. Pharm. Sci. Li 10 81 2015 10.1016/j.ajps.2014.09.004 A review on phospholipids and their main applications in drug delivery systems 

  123. J. Chromatogr. Liazid 1140 29 2007 10.1016/j.chroma.2006.11.040 Investigation on phenolic compounds stability during microwave-assisted extraction 

  124. Int. J. Mol. Sci. Lin 12 5946 2011 10.3390/ijms12095946 Study on the stability of deoxyArbutin in an anhydrous emulsion system 

  125. Int. J. Pharm. Lopez 200 127 2000 10.1016/S0378-5173(00)00365-3 Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone 

  126. Malaysian J. Pharm. Sci. Madhavi 11 49 2013 Enhanced transdermal drug penetration of curcumin via ethosomes 

  127. Majmudar, G., Zhao, W., 2006. Skin lightening compositions. WO patent 2006102289 A3. 

  128. Arabian J. Chem. Malik 5 397 2012 10.1016/j.arabjc.2010.09.027 Microemulsion method: a novel route to synthesize organic and inorganic nanomaterials 

  129. Int. J. Pharm. Manosroi 293 235 2005 10.1016/j.ijpharm.2005.01.009 Enhancement of the release of azelaic acid through the synthetic membranes by inclusion complex formation with hydroxypropyl-β-cyclodextrin 

  130. J. Invest. Dermatol. Marmol 101 871 1993 10.1111/1523-1747.ep12371709 Glutathione depletion increases tyrosinase activity in human melanoma cells 

  131. Exp. Dermatol. Mastrofrancesco 19 813 2010 10.1111/j.1600-0625.2010.01107.x Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPARγ activation 

  132. Biosci. Biotechnol. Biochem. Masuda 69 197 2005 10.1271/bbb.69.197 Screening for tyrosinase inhibitors among extracts of seashore plants and identification of potent inhibitors from garcinia subelliptica 

  133. Meybeck A., Dumas M., 1992. Composition containing a mulberry extract incorporated into hydrated lipidic lamellar phases of liposomes. US patent 5164182A. 

  134. Mosher 2 671 2006 Complexation: cyclodextrins 

  135. Adv. Drug Deliv. Rev. Muller 54 131 2002 10.1016/S0169-409X(02)00118-7 Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations 

  136. Int. J. Pharm. Muller 242 121 2002 10.1016/S0378-5173(02)00180-1 Nanostructured lipid matrices for improved microencapsulation of drugs 

  137. Int. J. Pharm. Pharm. Sci. Muzaffar 5 39 2013 Review on microemulsion as futuristic drug delivery 

  138. Nanbu, T., 2009. Whitening cosmetic composition containing arbutin nanoparticles. UD patent 20090069253 A1. 

  139. J. Am. Acad. Dermatol. Nazzaro-Porro 17 1033 1987 10.1016/S0190-9622(87)70294-1 Azelaic acid 

  140. J. Chromatogr. Sci. Nessa 43 416 2005 10.1093/chromsci/43.8.416 RP-HPLC method for the quantitative analysis of naturally occurring flavonoids in leaves of Blumea balsamifera DC 

  141. Int. J. Dermatol. Nguyen 34 75 1995 10.1111/j.1365-4362.1995.tb03583.x Azelaic acid: pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne 

  142. Phytother. Res. Ni 16 567 2002 10.1002/ptr.1085 Treatment of melasma with pycnogenol 

  143. Life Sci. No 65 241 1999 10.1016/S0024-3205(99)00492-0 Inhibition of tyrosinase by green tea components 

  144. Food Chem. Toxicol. Nohyneka 42 93 2004 10.1016/j.fct.2003.08.008 An assessment of the genotoxicity and human health risk of topical use of kojic acid [5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one] 

  145. J. Cosmet. Dermatol. O'Donoghue 5 196 2006 10.1111/j.1473-2165.2006.00253.x Hydroquinone and its analogues in dermatology −a risk-benefit viewpoint 

  146. Ochiai 2001 The 52nd Annual Meeting of the Central Division of Japanese Dermatological Association 2001 Effects of α-Toc on in vitro aged melanocytes 

  147. Int. J. Pharm. Pardeike 366 170 2009 10.1016/j.ijpharm.2008.10.003 Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products 

  148. Dermatol. Sin. Park 28 53 2010 10.1016/S1027-8117(10)60011-0 Biology of melanogenesis and the search for hypopigmenting agents 

  149. Free Radic. Res. Commun. Passi 15 17 1991 10.3109/10715769109049121 The oxyradical-scavenging activity of azelaic acid in biological systems 

  150. Asian J. Pharm. Pawar 10 425 2016 Transfersome: a novel technique which improves transdermal permeability 

  151. Pelliccia, M.T., Giannella, A., Giannella, J., 2001. Use of resveratrol for the treatment of exfoliative eczema, acne and psoriasis.US20010056071 A1. 

  152. Int. J. Pharm. Peltola 254 99 2003 10.1016/S0378-5173(02)00632-4 Microemlsions for topical delivery of estradiol 

  153. AAPS J. Qiao 16 101 2014 10.1208/s12248-013-9544-9 Identification of key licorice constituents which interact with cytochrome P450: evaluation by LC/MS/MS cocktail assay and metabolic profiling 

  154. J. Adv. Pharm. Technol. Res. Rajan 2 138 2011 10.4103/2231-4040.85524 Transferosomes −A vesicular transdermal delivery system for enhanced drug permeation 

  155. Food Chem. Toxicol. Rangkadilok 45 328 2007 10.1016/j.fct.2006.08.022 Evaluation of free radical scavenging and antityrosinase activities of standardized longan fruit extract 

  156. Int. J. Pharm. Rhee 228 161 2001 10.1016/S0378-5173(01)00827-4 Transdermal delivery of ketoprofen using microemulsions 

  157. Arch. Pharm. Res. Rhee 30 1155 2007 10.1007/BF02980252 Effects of vehicles and enhancers on transdermal delivery of clebopride 

  158. J. Agric. Food Chem. Rothwell 53 4355 2005 10.1021/jf0483669 Experimental determination of octanol- water partition coefficients of quercetin and related flavonoids 

  159. Pharm. Sci. Technol. Rozman 10 54 2009 10.1208/s12249-008-9172-3 Temperature-sensitive microemulsion gel: an effective topical delivery system for simultaneous delivery of vitamins C and E 

  160. J. Enzyme Inhib. Med. Chem. Ryu 23 922 2008 10.1080/14756360701810207 Inhibitory effects on mushroom tyrosinase by flavones from the stem barks of Morus lhou (S.) Koidz 

  161. SCCS (Scientific Committee on Consumer Safety, European Commission), Opinion on kojic acid, 26-27 June 2012, SCCP/1481/12. 

  162. SCCS (Scientific Committee on Consumer Safety, European Commission), Opinion on α- arbutin, 27 May 2015, SCCS/1552/15. 

  163. J. Med. Plants Res. Saewan 5 1018 2011 Anti-tyrosinase and anti-cancer activities of flavonoids from Blumea balsamifera DC 

  164. Sangster 2014 Log Kow, a Databank of Evaluated Octanol-Water Partition Coefficients (Log P) 

  165. Pharm. Res. Schipper 14 923 1997 10.1023/A:1012160102740 Chitosan as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement 

  166. Skin Pharmacol. Physiol. Schlupp 24 199 2011 10.1159/000324053 Drug release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoids 

  167. J. Clin. Aesthet. Dermatol. Schmidt 4 22 2011 Retinoin: a Review of its anti-inflammatory properties in the treatment of acne 

  168. J. Agric. Food Chem. Sessa 59 12352 2011 10.1021/jf2031346 Evaluation of the stability and antioxidant activity of nanoencapsulated resveratrol during in vitro digestion 

  169. Int. J. Pharm. Shaker 253 1 2003 10.1016/S0378-5173(02)00625-7 Mechanistic studies of the effect of hydroxypropyl-b-cyclodextrin on in vitro transdermal permeation of corticosterone through hairless mouse skin 

  170. Shefer, A., Shefer, S.D., 2003, Multi component controlled release system for anhydrous cosmetic compositons. US patent 20030198652 A1. 

  171. Syst. Rev. Pharm. Sheraz 2 86 2011 10.4103/0975-8453.86296 Formulation and stability of ascorbic acid in topical preparations 

  172. Biol. Pharm. Bull. Shigeta 27 591 2004 10.1248/bpb.27.591 Skin whitening effect of linoleic acid is enhanced by liposomal formulations 

  173. Biol. Pharm. Bull. Shigeta 27 879 2004 10.1248/bpb.27.879 Suppressed permeation of linoleic acid in a liposomal formulation through reconstructed skin tissue 

  174. Lipids Shimizu 36 1321 2001 10.1007/s11745-001-0847-9 Novel vitamin E derivative with 4-substituted resorcinol moiety has both antioxidant and tyrosinase inhibitory properties 

  175. J. Agric. Food Chem. Shoji 53 6105 2005 10.1021/jf050418m Procyanidin trimers to pentamers fractionated from apple inhibit melanogenesis in B16 mouse melanoma cells 

  176. J. Pharm. Sci. Siefert 86 716 1996 10.1021/js960389h Influence of alpha-cyclodextrin and hydroxyalkylated β-cyclodextrin derivatives on the in vitro corneal uptake and permeation of aqueous pilocarpine-HCl solutions 

  177. Photobiol. Sci. Silva 12 638 2013 10.1039/C2PP25239B Photochemical and photocatalytic degradation of trans-resveratrol 

  178. Fitoterapia Simmler 90 160 2013 10.1016/j.fitote.2013.07.003 Phytochemistry and biological properties of glabridin 

  179. J. Pharm. Sci. Technol. Singh 2 171 2010 Characterization of cyclodextrin inclusion complexes −a review 

  180. J. Control. Release Sinico 103 123 2005 10.1016/j.jconrel.2004.11.020 Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction 

  181. J. Drug Deliv. Sci. Technol. Sinico 16 115 2006 10.1016/S1773-2247(06)50017-6 Cutaneous delivery of 8-methoxypsoralen from liposoma and niosomal carriers 

  182. World J. Pharm. Pharm. Sci. Solanki 5 435 2016 Transferosomes-a review 

  183. Curr. Opin. Colloid Interface Sci. Solans 10 102 2005 10.1016/j.cocis.2005.06.004 Nano-emulsions 

  184. J. Chromatogr. A Soong 1085 270 2005 10.1016/j.chroma.2005.06.042 Isolation and structure elucidation of phenolic compounds from longan (Dimocarpus longan Lour.) seed by high-performance liquid chromatography electrospray ionization mass spectrometry 

  185. PLoS One Souza 7 e48589 2012 10.1371/journal.pone.0048589 Plants from Brazilian Cerrado with potent tyrosinase inhibitory activity 

  186. Int. J. Pharm. Spiclin 222 271 2001 10.1016/S0378-5173(01)00715-3 Stability of ascorbyl palmitate in topical microemulsions 

  187. Int. J. Nanomed. Subongkot 9 3539 2014 Investigation of the mechanism of enhanced skin penetration by ultradeformable liposomes 

  188. Int. J. Pharm. Sci. Res. Swathi 1 1 2010 Solid lipid nanoparticles: colloidal carrier systems for drug delivery 

  189. Adv. Drug Deliv. Rev. Takeuchi 47 39 2001 10.1016/S0169-409X(00)00120-4 Mucoadhesive nanoparticulate systems for peptide drug delivery 

  190. J. Control. Release Taveira 134 35 2009 10.1016/j.jconrel.2008.11.002 Effect of the iontophoresis of a chitosan gel on doxorubicin skin penetration and cytotoxicity 

  191. J. Dermatol. Surg. Oncol. Taylor 20 592 1994 10.1111/j.1524-4725.1994.tb00152.x Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser 

  192. Int. J. Pharm. Teeranachaideekul 340 198 2007 10.1016/j.ijpharm.2007.03.022 Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)-Effects of formulation parameters on physicochemical stability 

  193. Eur. J. Pharm. Biopharm. Teichmann 67 699 2007 10.1016/j.ejpb.2007.04.006 Comparison of stratum corneum penetration and localization of a lipophilic model drug applied in an o/w microemulsion and an amphiphilic cream 

  194. Eur. J. Res. Med. Sci. Thach 5 1 2017 Antioxidant and antityrosinase activities of flavonoid from Blumea Balsamifera (L.) DC. Leaves extract 

  195. Pharm. Dev. Technol. Thakkar 19 373 2014 10.3109/10837450.2013.788658 Transdermal delivery of diclofenac using water-in-oil microemulsion: formulation and mechanistic approach of drug skin permeation 

  196. Pharmacogn. J. Tilaar 9 235 2017 10.5530/pj.2017.2.39 The efficacy study of snake fruit (Salacca edulis Reinw Var: Bongkok) extract as skin lightening agent 

  197. J. Control. Release Touitou 65 403 2000 10.1016/S0168-3659(99)00222-9 Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties 

  198. Traber 396 2006 Modern Nutrition in Health and Desease Vitamin e 

  199. US EPA 2004 Estimation Program Interface (EPI) Suite. Ver. 3.12 

  200. US EPA 2010 Estimation Program Interface (EPI) Suite. Ver. 4 

  201. J. Jpn. Cosmet. Sci. Soc. Uehara 27 247 2003 Inhibitory effects of proanthocyanidin-rich extracts from grape seeds on melanogenesis 

  202. Med. Chem. Um 11 5345 2003 10.1016/j.bmc.2003.09.046 Synthesis of new glycyrrhetinic acid (GA) derivatives and their effects on tyrosinase activity. Bioorg 

  203. Pharmazie Uner 60 577 2005 Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for application of ascorbylpalmitate 

  204. Int. J. Pharm. Ustündağ Okur 416 136 2011 Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations 

  205. J. Adv. Pharm. Technol. Res. Verma 1 274 2010 10.4103/0110-5558.72415 Therapeutic and cosmeceutical potential of ethosomes: an overview 

  206. Eur. J. Pharm. Biopharm. Verma 55 271 2003 10.1016/S0939-6411(03)00021-3 Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study 

  207. Int. J. Pharm. Vianna 167 205 1998 10.1016/S0378-5173(98)00068-4 Formation of cyclodextrin inclusion complexes with corticosteroids: their characterization and stability 

  208. Viladot Petit, J.L., De Moragas, M., 2003. Skincare agents. US patent 20030044469 A1. 

  209. Viladot Petit, J.L., Delgado Conzalez, R., Fernandez Botello, A., 2013. Lipid nanoparticle capsules. US patent 20130017239 A1. 

  210. Dermatol. Surg. Wattanakrai 36 76 2010 10.1111/j.1524-4725.2009.01383.x Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064nm) laser for the treatment of facial melasma in Asians 

  211. Arch. Pharm. Res. Wen 29 1187 2006 10.1007/BF02969312 Formulation of liposome for topical delivery of arbutin 

  212. Biochem. (Mosc.) Xie 68 487 2003 10.1023/A:1023620501702 Inhibitory effects of some flavonoids on the activity of mushroom tyrosinase 

  213. Pigment. Cell. Res. Yamakoshi 16 629 2003 10.1046/j.1600-0749.2003.00093.x Lightening effect on ultraviolet-induced pigmentation of guinea pig skin by oral administration of proanthocyanidin-rich extract from grape seeds 

  214. Phytother. Res. Yamakoshi 18 895 2004 10.1002/ptr.1537 Oral intake of proanthocyanidin-rich extract from grape seeds improves chloasma 

  215. Lipids Yamauchi 37 515 2002 10.1007/s11745-002-0926-y Analysis of vitamin E and its oxidation products by HPLC with electrochemical detection 

  216. Microchem. J. Yang 92 87 2009 10.1016/j.microc.2009.02.001 The effect of the molecular weight of chitosan nanoparticles and its application on drug delivery 

  217. Int. J. Mol. Sci. Yang 11 3977 2010 10.3390/ijms11103977 Determination of the thermodegradation of deoxyArbutin in aqueous solution by high performance liquid chromatography 

  218. Pigment. Cell. Res. Yokota 11 355 1998 10.1111/j.1600-0749.1998.tb00494.x The inhibitory effect of glabridin from liquorice extracts on melanogenesis and inflammation 

  219. J. Agric. Food Chem. Yuan 46 5078 1998 10.1021/jf9805404 Degradation of ascorbic acid in aqueous solution 

  220. Skin Pharmacol. Appl. Skin Physiol. Zhai 14 1 2001 10.1159/000056328 Effects of skin occlusion on percutaneous absorption: an overview 

  221. J. Enzyme Inhib. Med. Chem. Zhang 22 83 2007 10.1080/14756360600953876 Tyrosinase inhibitory effects and inhibition mechanisms of nobiletin and hesperidin from citrus peel crude extracts 

  222. Nanomedicine Zhang 8 1026 2012 10.1016/j.nano.2011.10.006 In vitro study of ethosome penetration in human skin and hypertrophic scar tissue 

  223. World J. Pharm. Pharm. Sci. Zhou 3 167 2014 Inhibitory effects and mechanism of flavonoids from Xanthoceras Sorbifolia Bunge on tyrosinase 

  224. J. Investig. Dermatol. Symp. Proc. Zhu 13 20 2008 10.1038/jidsymp.2008.8 The use of botanical extracts as topical skin-lightening agents for the improvement of skin pigmentation disorders 

  225. Zhu vol. 30 205 2006 

  226. C&T Zuidhoff 116 53 2001 Whitening efficacy of frequently used whitenning ingredients 

  227. Eur. J. Pharm. Biopharm. Zupancic 93 196 2015 10.1016/j.ejpb.2015.04.002 Stability and solubility of trans-resveratrol are strongly influenced by pH and temperature 

  228. Drug Deliv. Zylberberg 23 3319 2016 10.1080/10717544.2016.1177136 Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape 

  229. PLoS One de Freitas 11 e0163130 2016 10.1371/journal.pone.0163130 Extracts of Morus nigra L leaves standardized in chlorogenic acid, rutin and isoquercitrin:tyrosinase inhibition and cytotoxicity 

관련 콘텐츠

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로